Literature DB >> 27080569

Variable cost of ICU care, a micro-costing analysis.

Dimitra Karabatsou1, Maria Tsironi2, Evdoxia Tsigou3, Eleni Boutzouka4, Theodoros Katsoulas5, George Baltopoulos6.   

Abstract

Intensive care unit (ICU) costs account for a great part of a hospital's expenses. The objective of the present study was to measure the patient-specific cost of ICU treatment, to identify the most important cost drivers in ICU and to examine the role of various contributing factors in cost configuration. A retrospective cost analysis of all ICU patients who were admitted during 2011 in a Greek General, seven-bed ICU and stayed for at least 24hours was performed, by applying bottom-up analysis. Data collected included demographics and the exact cost of every single material used for patients' care. Prices were yielded from the hospital's purchasing costs and from the national price list of the imaging and laboratory tests, which was provided by the Ministry of Health. A total of 138 patients were included. Variable cost per ICU day was €573.18. A substantial cost variation was found in the total costs obtained for individual patients (median: €3443, range: €243.70-€116,355). Medicines were responsible for more than half of the cost and antibiotics accounted for the largest part of it, followed by blood products and cardiovascular drugs. Medical cause of admission, severe illness and increased length of stay, mechanical ventilation and dialysis were the factors associated with cost escalation. ICU variable cost is patient-specific, varies according to each patient's needs and is influenced by several factors. The exact estimation of variable cost is a pre-requisite in order to control ICU expenses.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bottom-up cost analysis; Cost; Costing methodologies; Intensive care; Top-down cost analysis; Variable cost

Mesh:

Year:  2016        PMID: 27080569     DOI: 10.1016/j.iccn.2016.01.001

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  7 in total

1.  Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study.

Authors:  Tim M J Ewoldt; Alan Abdulla; Nicole G M Hunfeld; Anouk E Muller; Diederik Gommers; Suzanne Polinder; Birgit C P Koch; Henrik Endeman
Journal:  Ther Drug Monit       Date:  2022-02-01       Impact factor: 3.118

2.  The Society of Critical Care Medicine at 50 Years: Interprofessional Practice in Critical Care: Looking Back and Forging Ahead.

Authors:  Ruth Kleinpell; W Robert Grabenkort; Walter A Boyle; David L Vines; Keith M Olsen
Journal:  Crit Care Med       Date:  2021-12-01       Impact factor: 9.296

3.  Survival predictors after intubation in medical wards: A prospective study in 151 patients.

Authors:  Dimitrios Basoulis; Stavros Liatis; Marina Skouloudi; Konstantinos Makrilakis; Georgios L Daikos; Petros P Sfikakis
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

4.  ICU-Associated Costs during the Fourth Wave of the COVID-19 Pandemic in a Tertiary Hospital in a Low-Vaccinated Eastern European Country.

Authors:  Mihai Popescu; Oana Mara Ştefan; Mihai Ştefan; Liana Văleanu; Dana Tomescu
Journal:  Int J Environ Res Public Health       Date:  2022-02-04       Impact factor: 3.390

Review 5.  Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review.

Authors:  Claudia Fischer; Susanne Mayer; Nataša Perić; Judit Simon
Journal:  Health Econ Rev       Date:  2022-08-03

6.  Characteristics and resource utilization of high-cost users in the intensive care unit: a population-based cohort study.

Authors:  Claudia Dziegielewski; Robert Talarico; Haris Imsirovic; Danial Qureshi; Yasmeen Choudhri; Peter Tanuseputro; Laura H Thompson; Kwadwo Kyeremanteng
Journal:  BMC Health Serv Res       Date:  2021-12-06       Impact factor: 2.655

7.  Quick diagnosis units: predictors of time to diagnosis and costs.

Authors:  Elisabet Montori-Palacín; Jordi Ramon; Yaroslau Compta; Monica Insa; Sergio Prieto-González; Ignasi Carrasco-Miserachs; Rafel X Vidal-Serra; Jordi Altes-Capella; Alfons López-Soto; Xavier Bosch
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.